| Real-world heart failure management in 910 patients with chronic heart failure in the Netherlands |
11 |
| 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group |
11 |
| A primer in artificial intelligence in cardiovascular medicine |
9 |
| Telemedicine in heart failure-more than nice to have? |
9 |
| Changes in automated external defibrillator use and survival after out-of-hospital cardiac arrest in the Nijmegen area |
8 |
| Prevalence and cardiac phenotype of patients with aphospholamban mutation |
8 |
| Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging cardiologist |
8 |
| A mobile one-lead ECG device incorporated in a symptom-driven remote arrhythmia monitoring program. The first 982 Hartwacht ECGs |
7 |
| PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design |
6 |
| Cardiac amyloidosis: the need for early diagnosis |
6 |
| Cardio-oncology: an overview on outpatient management and future developments |
5 |
| Sex differences in coronary artery plaque composition detected by coronary computed tomography: quantitative and qualitative analysis |
5 |
| Inherited cardiomyopathies and sports participation |
5 |
| Trends in patient characteristics and clinical outcome over 8 years of transcatheter aortic valve implantation |
5 |
| CTCA for detection of significant coronary artery disease in routine TAVI work-up: Asystematic review and meta-analysis |
4 |
| Multidisciplinary decision-making in mitral valve disease: the mitral valve heart team |
4 |
| Incidence, angiographic and clinical predictors, and impact of stent thrombosis: a6-year survey of 545 consecutive patients |
4 |
| Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance |
4 |
| Ethnic disparities in estimated cardiovascular disease risk in Amsterdam, the Netherlands |
4 |
| Extra energy for hearts with agenetic defect: ENERGY trial |
4 |
| Mechanisms of atrial fibrillation in athletes: what we know and what we do not know |
4 |
| Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands |
4 |
| Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions |
4 |
| Driving restrictions for Dutch patients with an implantable cardioverter defibrillator |
4 |
| Optimal pharmacological therapy in ST-elevation myocardial infarction-a review |
4 |
| Optimal duration of dual antiplatelet therapy for coronary artery disease |
4 |
| A practical guide on how to handle patients with bleeding events while on oral antithrombotic treatment |
3 |
| Different outcomes of a cardiac rehabilitation programme in functional parameters among myocardial infarction survivors according to ejection fraction |
3 |
| Circumstances and causes of sudden circulatory arrests in the Dutch province of Limburg and the involvement of citizen rescuers |
3 |
| Instantaneous wave-free ratio and fractional flow reserve in clinical practice |
3 |
| Competence of general practitioners in requesting and interpreting ECGs - a case vignette study |
3 |
| A new consensus document on electrocardiographic interpretation in athletes: does it help to prevent sudden cardiac death in athletes? |
3 |
| Pre-participation screening of asymptomatic athletes |
3 |
| Sudden cardiac arrest on the field of play: turning tragedy into a survivable event |
3 |
| Frailty score for elderly patients is associated with short-term clinical outcomes in patients with ST-segment elevated myocardial infarction treated with primary percutaneous coronary intervention |
3 |
| Short versus long duration of dual antiplatelet therapy following drug-eluting stents: a meta-analysis of randomised trials |
3 |
| Myocardial infarction with non-obstructive coronary arteries: afocus on vasospastic angina |
3 |
| Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands |
3 |
| First real-world experience with mobile health telemonitoring in adult patients with congenital heart disease |
3 |
| Visualisation of coronary venous anatomy by computed tomography angiography prior to cardiac resynchronisation therapy implantation |
3 |
| Magnetic resonance imaging in patients with cardiac implantable electronic devices |
2 |
| Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients |
2 |
| Red blood cell transfusion in patients with ST-elevation myocardial infarction-a meta-analysis of more than 000 patients |
2 |
| A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME3) trial |
2 |
| Effectiveness of web-based personalised e-Coaching lifestyle interventions |
2 |
| Large next-generation sequencing gene panels in genetic heart disease: challenges in clinical practice |
2 |
| Five-year results of the complete versus culprit vessel percutaneous coronary intervention in multivessel disease using drug-eluting stentsII (CORRECTII) study: aprospective, randomised controlled trial |
2 |
| Stroke risk in patients with device-detected atrial high-rate episodes |
2 |
| Catheter ablation of symptomatic idiopathic ventricular arrhythmias |
2 |
| Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia |
2 |
